Moreover, compared to proneural GBM, the mesenchymal GBM niche attracted high numbers of CD163+ TAMs and expressed elevated levels of PD-1/PD-L1 immune checkpoints and various cytokines (TGF-β1, IL-10, and CSF-1) [234]. The gene discussed is TGFB1; the disease is glioblastoma.